A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Study Summary

The purpose of this study is to evaluate long-term safety of subcutaneous guselkumab in pediatric participants with moderately to severely active ulcerative colitis, or moderately to severely active Crohn's disease, or juvenile psoriatic arthritis (jPsA).

Conditions

Crohns Disease Colitis, Ulcerative Arthritis, Psoriatic Arthritis, Juvenile

Interventions / Drugs

Guselkumab

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment196 participants

Primary Completion—

Lead SponsorJanssen Research & Development, LLC

Data Retrieved2026-04-11 02:55:31.550721+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.